Velcade in Myelodysplastic Syndrome - Pilot Study

NCT00440076 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

28

Enrollment

OTHER

Sponsor class

Stopped Low accrual

Conditions

MDS

Interventions

DRUG: Velcade

Sponsor

Gruppo Italiano Malattie EMatologiche dell'Adulto